Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02383927
What this trial is testing

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Who this might be right for
Thyroid CancerSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)HRAS Mutant Tumor+1 more
Kura Oncology, Inc. 63
Not applicableStudy completedNCT01247701
What this trial is testing

Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies

Who this might be right for
Myeloid Hematological Malignancies
Baylor College of Medicine 16
Early research (Phase 1)Looking for participantsNCT06387082
What this trial is testing

A Clinical Study of HMPL-506 in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Hutchmed 132
Testing effectiveness (Phase 2)Ended earlyNCT00957580
What this trial is testing

Trial of Pimasertib in Hematological Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteHematologic Neoplasms
EMD Serono 81
Testing effectiveness (Phase 2)Looking for participantsNCT05110742
What this trial is testing

Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances

Who this might be right for
Hematological Malignancy
M.D. Anderson Cancer Center 64
Not applicableNot Yet RecruitingNCT07039474
What this trial is testing

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

Who this might be right for
Solid Tumors and Hematological Tumors
Peking University First Hospital 120
Not applicableStudy completedNCT00440479
What this trial is testing

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

Who this might be right for
Multiple MyelomaHematological Neoplasms
Janssen-Cilag B.V. 11
Not applicableStudy completedNCT00582894
What this trial is testing

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

Who this might be right for
Hematological NeoplasmsHematopoietic Stem Cell Transplantation
University of Oklahoma 17
Early research (Phase 1)Study completedNCT00088101
What this trial is testing

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+1 more
Synta Pharmaceuticals Corp. 42
Not applicableActive Not RecruitingNCT06583512
What this trial is testing

Treatment Duration of IPA

Who this might be right for
Invasive AspergillosisAntifungal Therapy
Peking University People's Hospital 15
Very early researchStudy completedNCT01557686
What this trial is testing

Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study

Who this might be right for
Acute Leukemia
Universitetshospitalernes Center for Sygepleje 20
Testing effectiveness (Phase 2)UnknownNCT03366324
What this trial is testing

Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 20
Testing effectiveness (Phase 2)Looking for participantsNCT07719946
What this trial is testing

To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers

Who this might be right for
Haploidentical Hematopoietic Stem Cell TransplantHematological Malignancies
Tata Memorial Centre 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06180499
What this trial is testing

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Who this might be right for
Hematological MalignanciesRegulatory T Cell DepletionRelapse
Assistance Publique - Hôpitaux de Paris 27
Not applicableUnknownNCT00163644
What this trial is testing

RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT

Who this might be right for
Hematological Malignancies
Bayside Health 66
Not applicableStudy completedNCT06378853
What this trial is testing

Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients

Who this might be right for
Pancreatic Cancer
Jinling Hospital, China 548
Early research (Phase 1)Active Not RecruitingNCT03145181
What this trial is testing

Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematological Malignancies
Janssen Research & Development, LLC 302
Early research (Phase 1)UnknownNCT05020639
What this trial is testing

TQB3820 in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 116
Testing effectiveness (Phase 2)Ended earlyNCT02937675
What this trial is testing

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies

Who this might be right for
Lymphoma
Effector Therapeutics 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Next Page